T 0531/04 (Combination therapy for HCV/SCHERING) of 18.11.2005
- European Case Law Identifier
- ECLI:EP:BA:2005:T053104.20051118
- Date of decision
- 18 November 2005
- Case number
- T 0531/04
- Petition for review of
- -
- Application number
- 98306332.2
- IPC class
- A61K 38/21
- Language of proceedings
- English
- Distribution
- Distributed to board chairmen (C)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infection
- Applicant name
- SCHERING CORPORATION
- Opponent name
- Alfa Wassermann S.p.A.
Teva Pharmaceutical Industries Ltd.
Sandoz GmbH
Appelt, Christian W.
Meduna Arzneimittelfabrik GmbH - Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 112(1) 1973European Patent Convention Art 123(2) 1973European Patent Convention Art 123(3) 1973European Patent Convention Art 52(4) 1973European Patent Convention Art 54 1973European Patent Convention Art 56 1973European Patent Convention Art 87(4) 1973
- Keywords
- Objection under Art. 123(3) EPC (not admitted); right to priority (no); inventive step (no); referral to the EBA (no)
- Catchword
- -
- Citing cases
- T 1545/08
ORDER
For these reasons it is decided that:
1. The request of the appellant to refer questions to the Enlarged Board of Appeal is refused.
2. The appeal is dismissed.